Asia Vital Components (3017) Q4 2024 earnings summary

Executive summary

• Sales revenue for 2024 reached NTD 718 hundred million (NT$71,761,296 thousand), up 21.3% year-over-year, with net income up 58% to NTD 82 hundred million (NT$9,192,677 thousand).

• EPS grew 50.3% year-over-year to NTD 21.21 basic and NTD 20.62 diluted, continuing a multi-year upward trend.

• Revenue CAGR over the past years stands at 16.3%, and EPS CAGR at 48.1%.

• The audit opinion was unqualified, confirming fair presentation of financials in accordance with IFRS and local regulations.

• Major customers accounted for over 55% of net sales, with the top customer representing 28.61% in 2024.

Financial highlights

• Gross margin improved to 24% in 2024 from 21% in 2023, a 2.6 percentage point increase.

• Operating income rose 45.9% year-over-year to NTD 108 hundred million (NT$10,822,659 thousand), with operating margin up to 15.1%.

• Net non-operating items contributed NTD 16 hundred million, up 166.7% year-over-year.

• Free cash flow was NTD 51 hundred million, down 22.7% from the prior year.

• Cash and cash equivalents at year-end were NTD 299 hundred million (NT$29,923,508 thousand), up 10.7% year-over-year.

Outlook and guidance

• The company continues to invest in capacity expansion, including new factory construction in Vietnam and Dongguan.

• Management expects ongoing growth in Asia and overseas markets, supported by strong customer demand and product innovation.

• No material impact is expected from new or amended IFRS standards in the near term.